Indonesia’s new patent law has raised alarm over potential barriers to accessing life-saving medicines
Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
Daniel Jadue, a member of the Communist Party of Chile and the former mayor of Recoleta, was released after being held in preventative detention for 91 days
The Colombian government recently issued a compulsory license for HIV drug dolutegravir, making the treatment more accessible for thousands of people
New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South
Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
In a bid for transparency, health activists and civil society in South Africa have published the details of COVID-19 vaccine contracts between pharmaceutical giants and government. This follows a Pretoria High Court order instructing the Department of Health to disclose the contracts and proceedings of meetings pertaining to the procurement of vaccine doses
A new CDC study shows that 9 million people are trying to save money by rationing medication, as pharmaceutical giants rally against price checks
The UK-India FTA could have a drastic impact on the cost of drugs as well as the timely entry of generic medicines in India and other developing countries.
Pharmaceutical companies are trying to undermine a decision of the Brazilian Supreme Court from 2021 which puts health ahead of private profit